Title of the presentation

References

In Vitro Companion Diagnostic Devices, FDA, Guidance for Industry and Food and Drug Administration Staff, August 6, 2014 Principles for Codevelopment of an In Vitro Companion Diagnostic Device with a Therapeutic Product, FDA, Draft Guidance for Industry and Food and Drug Administration Staff, July 15, 2016 MHRA Guidance: Medical device stand-alone software including apps (including IVDMds) Available at: https://www.gov.uk/government/publications/medical-devices-software- applications-apps (Accessed: 27 January 2018)

Bettegowda et al.Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies. Sci Transl Med 19 February 2014 6:224ra24

Scheerens H et. al. (2017), Current Status of Companion and Complementary Diagnostics: Strategic Considerations for Development and Launch, DOI 10.1111/cts.12455

Theoret M. Biomarkers for PD-1/L1 inhibitors: Regulatory Consideration. Presentation at the EMA-CDDF Joint Meeting, 4 February 2016.

TOPRA MASTERCLASS FEB 2018 – FOR COURSE USE ONLY

Made with FlippingBook Annual report